180 related articles for article (PubMed ID: 31090579)
1. An update in the management of pediatric sarcoma.
Sandler G; Yokoi A; Hayes-Jordan A
Curr Opin Pediatr; 2019 Jun; 31(3):368-377. PubMed ID: 31090579
[TBL] [Abstract][Full Text] [Related]
2. Malignant soft tissue tumors in children.
Thacker MM
Orthop Clin North Am; 2013 Oct; 44(4):657-67. PubMed ID: 24095080
[TBL] [Abstract][Full Text] [Related]
3. Nonrhabdomyosarcoma soft tissue sarcoma (NRSTS).
Chui CH
Surg Oncol; 2007 Nov; 16(3):187-93. PubMed ID: 17707639
[TBL] [Abstract][Full Text] [Related]
4. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.
Lazo de la Vega L; Hovelson DH; Cani AK; Liu CJ; McHugh JB; Lucas DR; Thomas DG; Patel RM; Tomlins SA
Hum Pathol; 2016 Dec; 58():161-170. PubMed ID: 27664537
[TBL] [Abstract][Full Text] [Related]
5. Advances in the Molecular Analysis of Soft Tissue Tumors and Clinical Implications.
Marino-Enriquez A
Surg Pathol Clin; 2015 Sep; 8(3):525-37. PubMed ID: 26297069
[TBL] [Abstract][Full Text] [Related]
6. [The necessity and urgency of molecular analysis in the diagnosis and treatment of bone and soft tissue sarcomas].
Niu XH; Xu HR
Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(31):2399-2404. PubMed ID: 36000368
[TBL] [Abstract][Full Text] [Related]
7. What Would Next Generation Sequencing Bring to the Diagnosis and Treatment of Sarcomas? A Series of 20 Cases, a Single Institution's Experience.
Kulaç İ; Bulutay P; Meriçöz ÇA
Turk Patoloji Derg; 2021; 37(3):226-232. PubMed ID: 34514574
[TBL] [Abstract][Full Text] [Related]
8. Soft tissue sarcoma in children: prognosis and management.
Koscielniak E; Morgan M; Treuner J
Paediatr Drugs; 2002; 4(1):21-8. PubMed ID: 11817983
[TBL] [Abstract][Full Text] [Related]
9. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.
Ruymann FB; Grovas AC
Cancer Invest; 2000; 18(3):223-41. PubMed ID: 10754991
[TBL] [Abstract][Full Text] [Related]
10. SEOM Clinical Guideline of management of soft-tissue sarcoma (2016).
López-Pousa A; Martin Broto J; Martinez Trufero J; Sevilla I; Valverde C; Alvarez R; Carrasco Alvarez JA; Cruz Jurado J; Hindi N; Garcia Del Muro X
Clin Transl Oncol; 2016 Dec; 18(12):1213-1220. PubMed ID: 27905051
[TBL] [Abstract][Full Text] [Related]
11. Pediatric nonrhabdomyosarcoma soft tissue sarcomas.
Spunt SL; Skapek SX; Coffin CM
Oncologist; 2008 Jun; 13(6):668-78. PubMed ID: 18586922
[TBL] [Abstract][Full Text] [Related]
12. Establishing biomarkers for soft tissue sarcomas.
Czarnecka AM; Chmiel P; Błoński P; Rutkowski P
Expert Rev Anticancer Ther; 2024 Jun; 24(6):407-421. PubMed ID: 38682679
[TBL] [Abstract][Full Text] [Related]
13. Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.
Szurian K; Kashofer K; Liegl-Atzwanger B
Pathobiology; 2017; 84(6):323-338. PubMed ID: 28817827
[TBL] [Abstract][Full Text] [Related]
14. Soft tissue sarcomas in children.
Pappo AS; Parham DM; Rao BN; Lobe TE
Semin Surg Oncol; 1999 Mar; 16(2):121-43. PubMed ID: 9988868
[TBL] [Abstract][Full Text] [Related]
15. Soft tissue sarcomas.
Lawrence W; Neifeld JP
Curr Probl Surg; 1989 Nov; 26(11):753-827. PubMed ID: 2686945
[TBL] [Abstract][Full Text] [Related]
16. Pediatric soft tissue sarcomas of nonmyogenic origin.
McCoy DM; Levine EA; Ferrer K; Das Gupta TK
J Surg Oncol; 1993 Jul; 53(3):149-53. PubMed ID: 8331936
[TBL] [Abstract][Full Text] [Related]
17. Current approach to pediatric soft tissue sarcomas.
Merchant MS; Mackall CL
Oncologist; 2009 Nov; 14(11):1139-53. PubMed ID: 19897537
[TBL] [Abstract][Full Text] [Related]
18. [Soft tissue sarcomas: clinical application of molecular biology].
Chetaille B; Laibe S; Choukeir N; Bertucci F
Rev Prat; 2013 Mar; 63(3):309-13. PubMed ID: 23687749
[TBL] [Abstract][Full Text] [Related]
19. A guide to oncological management of soft tissue tumours of the abdominal wall.
Williams KJ; Hayes AJ
Hernia; 2014 Feb; 18(1):91-7. PubMed ID: 24043554
[TBL] [Abstract][Full Text] [Related]
20. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]